Archives

by in
Entry Author Date Location
Vertex Wins EU Approval for Cystic Fibrosis Drug 07/27/12 Boston
Tesaro, Vertex, Infraredx, & More Boston Life Sciences Headlines 06/29/12 Boston
After Big Oops, Vertex Plows Ahead With Cystic Fibrosis Drug Combo 06/28/12 Boston
Three Good Things About BIO 2012, and Four Not-so-Good 06/18/12 National
Acucela, Turning 10, Gears Up for Pivotal Test With Eye Drug 06/12/12 Seattle
Vertex, N-of-One, Flexion & More Boston Life Sciences News 06/01/12 Boston
Vertex Shares Drop on Mistake in Cystic Fibrosis Drug Data 05/29/12 Boston
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
Boston Life Sciences News From Vertex, Eleven, RXi, & More 05/11/12 Boston
Vertex Shares Boom on Cystic Fibrosis Results 05/07/12 Boston
Investing in Biotech Isn’t Just for Investors Anymore 04/09/12 National
Late Add: John Mendlein Joins “Reinventing Biotech” Lineup April 3 03/29/12 Seattle
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks 03/26/12 National
Enanta, Satori, Vertex & More of the Week’s Life Sciences Newsmakers 02/24/12 Boston
Vertex Stays in HepC Game, as All-Oral Combo Passes Small Study 02/23/12 Boston
Enanta Enters HepC Big Leagues, With $34M Upfront From Novartis 02/21/12 Boston
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News 02/03/12 Boston
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says 02/01/12 Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug 01/31/12 Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers 01/27/12 Boston
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More 01/26/12 San Diego
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
The Top 10 Traffic-Getting Stories at Xconomy San Diego 12/28/11 San Diego
San Diego Life Sciences Roundup: BeneChill, Sotera, Imthera, & More 12/16/11 San Diego
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition 12/15/11 Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News 11/11/11 Boston
Vertex Stock Drops 17% Over Two Days, As Potent Hep C Rivals Emerge 11/08/11 Boston
Page 3 of 10 « previous page · next page »